Antiproliferation activity of a small molecule repressor of liver receptor homolog 1

Molecular Pharmacology

Volumn 87, Issue 2, 2015, Pages 296-304

  Corzo, Cesar A ^a   Mari, Yelenis ^a   Chang, Mi Ra ^a   Khan, Tanya ^a   Kuruvilla, Dana ^a   Nuhant, Philippe ^a   Kumar, Naresh ^a   West, Graham M ^a   Duckett, Derek R ^a   Roush, William R ^a   Griffin, Patrick R ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

6 [4 (3 CHLOROPHENYL) PIPERAZIN 1 YL] 3 CYCLOHEXYL 1H PYRIMIDINE 2,4 DIONE; CYCLIN D1; CYCLIN E1; CYCLINE; LIVER RECEPTOR HOMOLOG 1; REPRESSOR PROTEIN; SMALL INTERFERING RNA; UNCLASSIFIED DRUG; CELL RECEPTOR; NR5A2 PROTEIN, MOUSE; PYRIMIDINE DERIVATIVE;

ANIMAL TISSUE; ANTIPROLIFERATIVE ACTIVITY; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; CYTOPLASM; EMBRYO; FEMALE; GENE EXPRESSION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; MOUSE; NONHUMAN; REPORTER GENE; ANIMAL; ANTAGONISTS AND INHIBITORS; C57BL MOUSE; CHEMISTRY; DRUG EFFECTS; HEK293 CELL LINE; HEPG2 CELL LINE; METABOLISM; PHYSIOLOGY;

ANIMALS; CELL PROLIFERATION; HEK293 CELLS; HEP G2 CELLS; HUMANS; MICE; MICE, INBRED C57BL; PYRIMIDINES; RECEPTORS, CYTOPLASMIC AND NUCLEAR;

EID: 84920613493     PISSN: 0026895X     EISSN: 15210111     Source Type: Journal    
DOI: 10.1124/mol.114.095554     Document Type: Article

References (32)

1. Benod C, Carlsson J, Uthayaruban R, Hwang P, Irwin JJ, Doak AK, Shoichet BK, Sablin EP, and Fletterick RJ (2013) Structure-based discovery of antagonists of nuclear receptor LRH-1. J Biol Chem 288: 19830-19844.
2. Benod C, Vinogradova MV, Jouravel N, Kim GE, Fletterick RJ, and Sablin EP (2011) Nuclear receptor liver receptor homologue 1 (LRH-1) regulates pancreatic cancer cell growth and proliferation. Proc Natl Acad Sci USA 108: 16927-16931.
3. Botrugno OA, Fayard E, Annicotte JS, Haby C, Brennan T, Wendling O, Tanaka T, Kodama T, Thomas W, and Auwerx J et al. (2004) Synergy between LRH-1 and beta-catenin induces G1 cyclin-mediated cell proliferation. Mol Cell 15: 499-509.
4. Bouchard MF, Taniguchi H, and Viger RS (2005) Protein kinase A-dependent syn-ergism between GATA factors and the nuclear receptor, liver receptor homolog-1, regulates human aromatase (CYP19) PII promoter activity in breast cancer cells. Endocrinology 146: 4905-4916.
5. Broadus J, McCabe JR, Endrizzi B, Thummel CS, and Woodard CT (1999) The Drosophila beta FTZ-F1 orphan nuclear receptor provides competence for stage-specific responses to the steroid hormone ecdysone. Mol Cell 3: 143-149.
6. Busby S, Nuhant P, Cameron M, Mercer BA, Hodder P, Roush WR, and Griffin PR (2010) Discovery of inverse agonists for the liver receptor homologue-1 (LRH1; NR5A2). In Probe Reports from the NIH Molecular Libraries Program. National Center for Biotechnology Information, Bethesda, MD.
7. Chalkiadaki A and Talianidis I (2005) SUMO-dependent compartmentalization in promyelocytic leukemia protein nuclear bodies prevents the access of LRH-1 to chromatin. Mol Cell Biol 25: 5095-5105.
8. Chand AL, Herridge KA, Thompson EW, and Clyne CD (2010) The orphan nuclear receptor LRH-1 promotes breast cancer motility and invasion. Endocr Relat Cancer 17: 965-975.
9. Clyne CD, Speed CJ, Zhou J, and Simpson ER (2002) Liver receptor homologue-1 (LRH-1) regulates expression of aromatase in preadipocytes. J Biol Chem 277: 20591-20597.
10. Fabian CJ (2007) The what, why and how of aromatase inhibitors: hormonal agents for treatment and prevention of breast cancer. Int J Clin Pract 61: 2051-2063.
11. Fayard E, Auwerx J, and Schoonjans K (2004) LRH-1: an orphan nuclear receptor involved in development, metabolism and steroidogenesis. Trends Cell Biol 14: 250-260.
12. Francis GA, Fayard E, Picard F, and Auwerx J (2003) Nuclear receptors and the control of metabolism. Annu Rev Physiol 65: 261-311.
13. Hadizadeh S, King DN, Shah S, and Sewer MB (2008) Sphingosine-1-phosphate regulates the expression of the liver receptor homologue-1. Mol Cell Endocrinol 283: 104-113.
14. Key TJ, Appleby PN, Reeves GK, Roddam AW, Helzlsouer KJ, Alberg AJ, Rollison DE, Dorgan JF, Brinton LA, and Overvad K et al.; Endogenous Hormones and Breast Cancer Collaborative Group (2011) Circulating sex hormones and breast cancer risk factors in postmenopausal women: reanalysis of 13 studies. Br J Cancer 105: 709-722.
15. Krylova IN, Sablin EP, Moore J, Xu RX, Waitt GM, MacKay JA, Juzumiene D, Bynum JM, Madauss K, and Montana V et al. (2005) Structural analyses reveal phosphatidyl inositols as ligands for the NR5 orphan receptors SF-1 and LRH-1. Cell 120: 343-355.
16. Laffitte BA, Joseph SB, Walczak R, Pei L, Wilpitz DC, Collins JL, and Tontonoz P (2001) Autoregulation of the human liver X receptor alpha promoter. Mol Cell Biol 21: 7558-7568.
17. Lavorgna G, Ueda H, Clos J, and Wu C (1991) FTZ-F1, a steroid hormone receptorlike protein implicated in the activation of fushi tarazu. Science 252: 848-851.
18. Lee JM, Lee YK, Mamrosh JL, Busby SA, Griffin PR, Pathak MC, Ortlund EA, and Moore DD (2011) A nuclear-receptor-dependent phosphatidylcholine pathway with antidiabetic effects. Nature 474: 506-510.
19. Lee YK, Choi YH, Chua S, Park YJ, and Moore DD (2006) Phosphorylation of the hinge domain of the nuclear hormone receptor LRH-1 stimulates transactivation. J Biol Chem 281: 7850-7855.
20. Li Y, Choi M, Cavey G, Daugherty J, Suino K, Kovach A, Bingham NC, Kliewer SA, and Xu HE (2005) Crystallographic identification and functional characterization of phospholipids as ligands for the orphan nuclear receptor steroidogenic factor-1. Mol Cell 17: 491-502.
21. Lin BC, Suzawa M, Blind RD, Tobias SC, Bulun SE, Scanlan TS, and Ingraham HA (2009) Stimulating the GPR30 estrogen receptor with a novel tamoxifen analogue activates SF-1 and promotes endometrial cell proliferation. Cancer Res 69: 5415-5423.
22. Luo X, Ikeda Y, and Parker KL (1994) A cell-specific nuclear receptor is essential for adrenal and gonadal development and sexual differentiation. Cell 77: 481-490.
23. Madoux F, Li X, Chase P, Zastrow G, Cameron MD, Conkright JJ, Griffin PR, Thacher S, and Hodder P (2008) Potent, selective and cell penetrant inhibitors of SF-1 by functional ultra-high-throughput screening. Mol Pharmacol 73: 1776-1784.
24. Musille PM, Pathak MC, Lauer JL, Hudson WH, Griffin PR, and Ortlund EA (2012) Antidiabetic phospholipid-nuclear receptor complex reveals the mechanism for phospholipid-driven gene regulation. Nat Struct Mol Biol 19: 532-537, S531-532.
25. Pineda Torra I, Jamshidi Y, Flavell DM, Fruchart JC, and Staels B (2002) Characterization of the human PPARalpha promoter: identification of a functional nuclear receptor response element. Mol Endocrinol 16: 1013-1028.
26. Rey J, Hu H, Kyle F, Lai CF, Buluwela L, Coombes RC, Ortlund EA, Ali S, Snyder JP, and Barrett AG (2012) Discovery of a new class of liver receptor homolog-1 (LRH-1) antagonists: virtual screening, synthesis and biological evaluation. ChemMedChem 7: 1909-1914.
27. Schoonjans K, Dubuquoy L, Mebis J, Fayard E, Wendling O, Haby C, Geboes K, and Auwerx J (2005) Liver receptor homolog 1 contributes to intestinal tumor formation through effects on cell cycle and inflammation. Proc Natl Acad Sci USA 102: 2058-2062.
28. Solomon IH, Hager JM, Safi R, McDonnell DP, Redinbo MR, and Ortlund EA (2005) Crystal structure of the human LRH-1 DBD-DNA complex reveals Ftz-F1 domain positioning is required for receptor activity. J Mol Biol 354: 1091-1102.
29. Venteclef N, Jakobsson T, Ehrlund A, Damdimopoulos A, Mikkonen L, Ellis E, Nilsson LM, Parini P, Jänne OA, and Gustafsson JA et al. (2010) GPS2-dependent corepressor/SUMO pathways govern anti-inflammatory actions of LRH-1 and LXRbeta in the hepatic acute phase response. Genes Dev 24: 381-395.
30. Whitby RJ, Dixon S, Maloney PR, Delerive P, Goodwin BJ, Parks DJ, and Willson TM (2006) Identification of small molecule agonists of the orphan nuclear receptors liver receptor homolog-1 and steroidogenic factor-1. J Med Chem 49: 6652-6655.
31. Whitby RJ, Stec J, Blind RD, Dixon S, Leesnitzer LM, Orband-Miller LA, Williams SP, Willson TM, Xu R, and Zuercher WJ et al. (2011) Small molecule agonists of the orphan nuclear receptors steroidogenic factor-1 (SF-1, NR5A1) and liver receptor homologue-1 (LRH-1, NR5A2). J Med Chem 54: 2266-2281.
32. Yumoto F, Nguyen P, Sablin EP, Baxter JD, Webb P, and Fletterick RJ (2012) Structural basis of coactivation of liver receptor homolog-1 by β-catenin. Proc Natl Acad Sci USA 109: 143-148.